Stem Cell Morphogen Delivery via Engineered Biomaterials
通过工程生物材料输送干细胞形态原
基本信息
- 批准号:8334391
- 负责人:
- 金额:$ 37.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-09-16 至 2016-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultBindingBiocompatible MaterialsBiologyCell SurvivalCell TherapyCellsCellularityChronicComplexDefectDegenerative DisorderDermalDevelopmentDevelopmental BiologyDiseaseDoseEmbryoEngineeringEngraftmentEnvironmentEvaluationExtracellular MatrixExtracellular Matrix ProteinsFetal DevelopmentFrightGeneral PopulationGlycosaminoglycansGoalsGrowth FactorHindlimbIn VitroIndividualInjuryLabelLaboratoriesLeadMammalsMediatingMethodsModificationMolecularMorphogenesisMusNatural regenerationNormal tissue morphologyPhenotypePluripotent Stem CellsPopulationProcessRattusRegenerative MedicineResearch PersonnelRetrievalSafetySignal TransductionSiteStagingStem cell transplantStem cellsStructureTherapeuticTimeTissuesTranslatingTransplantationWorkWound Healingbasebonecell typechemical synthesisembryonic stem cellengineering designextracellularfunctional improvementimprovedin vivoinjuredinsightinterestmimeticsmorphogensmultidisciplinaryparacrineregenerativestem cell differentiationstem cell populationstem cell therapytissue regenerationtissue repairtraittumorigenicwound
项目摘要
DESCRIPTION (provided by applicant): Functional tissue regeneration remains an elusive goal for the treatment of a variety of traumatic injuries and chronic degenerative diseases that afflict a significant portion of the general population. Although mammals successfully regenerate tissues during early stages of fetal development, this trait is irreversibly lost as mammals mature. The contrast between embryonic and adult wound healing mechanisms suggests that the microenvironment that facilitates proper tissue regeneration in embryos is distinctly different from that of adult somatic tissues. Therefore, obtaining and introducing the molecular constituents of embryonic microenvironments to sites of adult tissue injury or disease may alter the course of endogenous tissue repair, yielding functional neo-tissues. A number of stem cell therapies are being developed in an attempt to restore the cellularity of damaged tissues, and in most instances, despite low levels of engraftment and differentiation into mature cell types, transplanted stem cells evoke significant functional improvements in the regenerative potential of tissues, indicating that the factors produced by stem cells may in fact directly impact tissue morphogenesis. This concept suggests a potential paradigm shift in the development and application of regenerative stem cell therapies - from cell replacement substitutes to biocatalytic agents of tissue regeneration. Thus, the objective of this proposal is to develop engineered biomaterials capable of sequestering morphogenic factors produced by differentiating embryonic stem cells (ESCs) and to deliver ESC-derived morphogens to adult wound sites in order to enhance tissue regeneration. These studies will provide new insights into the regenerative function of pluripotent stem cells and mechanisms of mammalian tissue repair, as well as directly lead to the development of a new class of regenerative molecular therapeutics to treat a variety of traumatic injuries and degenerative diseases.
描述(由申请人提供):功能性组织再生仍然是一个难以实现的目标,用于治疗各种创伤性损伤和慢性退行性疾病,这些疾病困扰着相当一部分普通人群。虽然哺乳动物在胎儿发育的早期阶段成功地再生组织,但随着哺乳动物的成熟,这种特征不可逆转地消失了。胚胎和成人伤口愈合机制之间的对比表明,促进胚胎适当组织再生的微环境与成人体组织的微环境明显不同。因此,获得胚胎微环境的分子成分并将其引入成人组织损伤或疾病的部位可能会改变内源性组织修复的过程,产生功能性新组织。许多干细胞疗法正在开发中,试图恢复受损组织的细胞性,并且在大多数情况下,尽管移植和分化成成熟细胞类型的水平较低,但移植的干细胞引起组织再生潜力的显著功能改善,表明干细胞产生的因子实际上可能直接影响组织形态发生。这一概念表明再生干细胞疗法的开发和应用的潜在范式转变-从细胞替代替代品到组织再生的生物催化剂。因此,本提案的目的是开发能够隔离由分化的胚胎干细胞(ESC)产生的形态发生因子的工程生物材料,并将ESC衍生的形态发生因子递送至成人伤口部位以增强组织再生。这些研究将为多能干细胞的再生功能和哺乳动物组织修复机制提供新的见解,并直接导致一类新的再生分子疗法的发展,以治疗各种创伤性损伤和退行性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Todd C McDevitt其他文献
Todd C McDevitt的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Todd C McDevitt', 18)}}的其他基金
Defining Strategies to Target Energy Failure in Metabolically Vulnerable Human Cells
制定针对代谢脆弱的人体细胞能量衰竭的策略
- 批准号:
10053166 - 财政年份:2020
- 资助金额:
$ 37.63万 - 项目类别:
Human microtissues for in situ detection and functional measurement of adverse consequences caused by genome editing
用于原位检测和功能测量基因组编辑引起的不良后果的人体微组织
- 批准号:
9789925 - 财政年份:2018
- 资助金额:
$ 37.63万 - 项目类别:
Stem Cell Morphogen Delivery via Engineered Biomaterials
通过工程生物材料输送干细胞形态原
- 批准号:
9053169 - 财政年份:2015
- 资助金额:
$ 37.63万 - 项目类别:
Engineering Mesenchymal Stem Cell Microenvironments to Promote Immunomodulation
工程间充质干细胞微环境促进免疫调节
- 批准号:
9053165 - 财政年份:2014
- 资助金额:
$ 37.63万 - 项目类别:
Engineering Mesenchymal Stem Cell Microenvironments to Promote Immunomodulation
工程间充质干细胞微环境促进免疫调节
- 批准号:
8892066 - 财政年份:2014
- 资助金额:
$ 37.63万 - 项目类别:
Engineering Mesenchymal Stem Cell Microenvironments to Promote Immunomodulation
工程间充质干细胞微环境促进免疫调节
- 批准号:
8623963 - 财政年份:2014
- 资助金额:
$ 37.63万 - 项目类别:
Stem Cell Morphogen Delivery via Engineered Biomaterials
通过工程生物材料输送干细胞形态原
- 批准号:
8726721 - 财政年份:2011
- 资助金额:
$ 37.63万 - 项目类别:
Stem Cell Morphogen Delivery via Engineered Biomaterials
通过工程生物材料输送干细胞形态原
- 批准号:
8530968 - 财政年份:2011
- 资助金额:
$ 37.63万 - 项目类别:
Stem Cell Morphogen Delivery via Engineered Biomaterials
通过工程生物材料输送干细胞形态原
- 批准号:
8181664 - 财政年份:2011
- 资助金额:
$ 37.63万 - 项目类别:
Microfluidic perfusion control of embryonic stem cell differentiation
胚胎干细胞分化的微流体灌注控制
- 批准号:
7768933 - 财政年份:2010
- 资助金额:
$ 37.63万 - 项目类别:
相似海外基金
Fcy receptor (CD32) binding: comparison of the effect of binding on b cells from neonatal and adult cattle
Fcy受体(CD32)结合:对新生牛和成年牛b细胞的结合效果比较
- 批准号:
368005-2008 - 财政年份:2008
- 资助金额:
$ 37.63万 - 项目类别:
University Undergraduate Student Research Awards
Functional analysis of the Zinc finger E-box binding homeobox 1 (ZEB1/TCF8) gene in the multi-step leukemogenesis of adult T-cell leukemia/lymphoma
锌指 E 盒结合同源盒 1 (ZEB1/TCF8) 基因在成人 T 细胞白血病/淋巴瘤多步白血病发生中的功能分析
- 批准号:
19790344 - 财政年份:2007
- 资助金额:
$ 37.63万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Doctoral Dissertation Research: Binding Interpretations in Adult Bilingualism:
博士论文研究:成人双语的约束性解释:
- 批准号:
0616432 - 财政年份:2006
- 资助金额:
$ 37.63万 - 项目类别:
Standard Grant
Adult Age Differences in Binding Actors and Actions
约束演员和动作的成人年龄差异
- 批准号:
6757012 - 财政年份:2004
- 资助金额:
$ 37.63万 - 项目类别:
Dopamine Transporter Binding by PET in Adult ADHD
成人 ADHD 中 PET 与多巴胺转运蛋白的结合
- 批准号:
6612445 - 财政年份:2003
- 资助金额:
$ 37.63万 - 项目类别:
Dopamine Transporter Binding by PET in Adult ADHD
成人 ADHD 中 PET 与多巴胺转运蛋白的结合
- 批准号:
7187397 - 财政年份:2003
- 资助金额:
$ 37.63万 - 项目类别: